Cardiac function in mice lacking the glucagon-like peptide-1 receptor

Endocrinology

Volumn 144, Issue 6, 2003, Pages 2242-2252

  Gros, Robert ^a   You, Xiaomang ^a   Baggio, Laurie L ^a   Golam Kabir, M ^a   Muktafi Sadi, Al ^a   Mungrue, Imran N ^a   Parker, Thomas G ^a   Huang, Qingling ^a   Drucker, Daniel J ^a   Husain, Mansoor ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; G PROTEIN COUPLED RECEPTOR; GLUCAGON; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; INSULIN; PROTEIN C FOS; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; BLOOD PRESSURE; CALCIUM TRANSPORT; CONFERENCE PAPER; CONTROLLED STUDY; ECHOCARDIOGRAPHY; GENE DELETION; HEART FUNCTION; HEART LEFT VENTRICLE CONTRACTILITY; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART RATE; INSULIN TREATMENT; MOUSE; NONHUMAN; PRIORITY JOURNAL; STRESS;

ANIMALS; BLOOD PRESSURE; BODY WEIGHT; ECHOCARDIOGRAPHY; HEART; HEART DISEASES; HEART RATE; MALE; MICE; MICE, MUTANT STRAINS; MYOCARDIUM; RECEPTORS, GLUCAGON; SIGNAL TRANSDUCTION; STRESS; VENTRICULAR PRESSURE;

EID: 0038577144     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2003-0007     Document Type: Conference Paper

References (62)

1. Drucker DJ 2001 Minireview: the glucagon-like peptides. Endocrinology 142:521-527
2. Drucker DJ, Ehrlich P, Asa SL, Brubaker PL 1996 Induction of intestinal epithelial proliferation by glucagon-like peptide 2. Proc Natl Acad Sci USA 93:7911-7916
3. Drucker DJ 2001 Glucagon-like peptide 2. J Clin Endocrinol Metab 86:1759-1764
4. Kieffer TJ, Habener JF 1999 The glucagon-like peptides. Endocr Rev 20:876-913
5. Drucker DJ 2002 Biological actions and therapeutic potential of the glucagon-like peptides. Gastroenterology 122:531-544
6. MacNeil DJ, Occi JL, Hey PJ, Strader CD, Graziano MP 1994 Cloning and expression of a human glucagon receptor. Biochem Biophys Res Commun 198:328-334
7. Mayo KE, Miller LJ, Bataille D, Dalle S, Goke B, Thorens B, Drucker DJ 2003 International Union of Pharmacology. XXXV. The glucagon receptor family. Pharmacol Rev 55:167-194
8. Thorens B 1992 Expression cloning of the pancreatic β cell receptor for the gluco-incretin hormone glucagon-like peptide 1. Proc Natl Acad Sci USA 89:8641-8645
9. Campos RV, Lee YC, Drucker DJ 1994 Divergent tissue-specific and developmental expression of receptors for glucagon and glucagon-like peptide-1 in the mouse. Endocrinology 134:2156-2164
10. Bullock BP, Heller RS, Habener JF 1996 Tissue distribution of messenger ribonucleic acid encoding the rat glucagon-like peptide 1 receptor. Endocrinology 137:2968-2978
11. Munroe DG, Gupta AK, Kooshesh F, Vyas TB, Rizkalla G, Wang H, Demchyshyn L, Yang ZJ, Kamboj RK, Chen H, McCallum K, Sumner-Smith M, Drucker DJ, Crivici A 1999 Prototypic G protein-coupled receptor for the intestinotrophic factor glucagon-like peptide 2. Proc Natl Acad Sci USA 96:1569-1573
12. Yusta B, Huang L, Munroe D, Wolff G, Fantaske R, Sharma S, Demchyshyn L, Asa SL, Drucker DJ 2000 Enteroendocrine localization of GLP-2 receptor expression. Gastroenterology 119:744-755
13. Bjerknes M, Cheng H 2001 Modulation of specific intestinal epithelial progenitors by enteric neurons. Proc Natl Acad Sci USA 98:12497-12502
14. Drucker DJ 2001 Development of glucagon-like peptide-1-based pharmaceuticals as therapeutic agents for the treatment of diabetes. Curr Pharm Des 7:1399-1412
15. Holst JJ 1999 An intestinal hormone, signaling nutritional abundance, with an unusual therapeutic potential. Trends Endocrinol Metab 10:229-235
16. Seeley RJ, Blake K, Rushing PA, Benoit S, Eng J, Woods SC, D'Alessio D 2000 The role of CNS glucagon-like peptide-1 (7-36) amide receptors in mediating the visceral illness effects of lithium chloride. J Neurosci 20:1616-1621
17. Golpon HA, Puechner A, Welte T, Wichert PV, Feddersen CO 2001 Vasorelaxant effect of glucagon-like peptide-(7-36)amide and amylin on the pulmonary circulation of the rat. Regul Pept 102:81-86
18. Richter G, Feddersen O, Wagner U, Barth P, Goke R, Goke B 1993 GLP-1 stimulates secretion of macromolecules from airways and relaxes pulmonary artery. Am J Physiol 265:L374-L381
19. Edwards CM, Edwards AV, Bloom SR 1997 Cardiovascular and pancreatic endocrine responses to glucagon-like peptide-1(7-36) amide in the conscious calf. Exp Physiol 82:709-716
20. Barragan JM, Rodriguez RE, Blazquez E 1994 Changes in arterial blood pressure and heart rate induced by glucagon-like peptide-1-(7-36 amide) in rats. Am J Physiol 266:E459-E466
21. Yamamoto H, Lee CE, Marcus JN, Williams TD, Overton JM, Lopez ME, Hollenberg AN, Baggio L, Saper CB, Drucker DJ, Elmquist JK 2002 Glucagon-like peptide-1 receptor stimulation increases blood pressure and heart rate and activates autonomic regulatory neurons. J Clin Invest 110:43-52
22. Vila Petroff MG, Egan JM, Wang X, Sollott SJ 2001 Glucagon-like peptide-1 increases cAMP but fails to augment contraction in adult rat cardiac myocytes. Circ Res 89:445-452
23. Wei Y, Mojsov S 1995 Tissue-specific expression of the human receptor for glucagon-like peptide 1: brain, heart and pancreatic forms have the same deduced amino acid sequences. FEBS Lett 358:219-224
24. Alvarez E, Roncero I, Chowen JA, Thorens B, Blazquez E 1996 Expression of the glucagon-like peptide-1 receptor gene in rat brain. J Neurochem 66:920-927
25. Merchenthaler I, Lane M, Shughrue P 1999 Distribution of pre-pro-glucagon and glucagon-like peptide-1 receptor messenger RNAs in the rat central nervous system. J Comp Neurol 403:261-280
26. Barragan JM, Rodriguez RE, Eng J, Blazquez E 1996 Interactions of exendin-(9-39) with the effects of glucagon-like peptide-1-(7-36) amide and of exendin-4 on arterial blood pressure and heart rate in rats. Regul Pept 67:63-68
27. Barragan JM, Eng J, Rodriguez R, Blazquez E 1999 Neural contribution to the effect of glucagon-like peptide-1-(7-36) amide on arterial blood pressure in rats. Am J Physiol 277:E784-E791
28. Scrocchi LA, Brown TJ, MacLusky N, Brubaker PL, Auerbach AB, Joyner AL, Drucker DJ 1996 Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide receptor gene. Nat Med 2:1254-1258
29. Feldman MD, Erikson JM, Mao Y, Korcarz CE, Lang RM, Freeman GL 2000 Validation of a mouse conductance system to determine LV volume: comparison to echocardiography and crystals. Am J Physiol Heart Circ Physiol 279:H1698-H1707
30. Mungrue IN, Gros R, You X, Pirani A, Azad A, Csont T, Schulz R, Butany J, Stewart DJ, Husain M 2002 Cardiomyocyte overexpression of iNOS in mice results in peroxyrdtrite generation, heart block, and sudden death. J Clin Invest 109:735-743
31. Schiller N, Shah P, Crawford M, De Maria A, Devereux R, Feigenbaum H, Gutgesell H, Reicheck N, Sahn D, Schnittger I, Silverman N, Tajik A 1989 American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms: recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr 2:358-367
32. Fortuin NJ, Hood Jr WP, Craige E 1972 Evaluation of left ventricular function by echocardiography. Circulation 46:26-35
33. Janssen BJ, Smits JF 2002 Autonomic control of blood pressure in mice: basic physiology and effects of genetic modification. Am J Physiol Regul Integr Comp Physiol 282:R1545-R1564
34. Janssen B, Debets J, Leenders P, Smits J 2002 Chronic measurement of cardiac output in conscious mice. Am J Physiol Regul Integr Comp Physiol 282:R928-R935
35. Drexler H, Hirth C, Stasch HP, Lu W, Neuser D, Just H 1990 Vasodilatory action of endogenous atrial natriuretic factor in a rat model of chronic heart failure as determined by monoclonal ANF antibody. Circ Res 66:1371-1380
36. Elias CF, Kelly JF, Lee CE, Ahima RS, Drucker DJ, Saper CB, Elmquist JK 2000 Chemical characterization of leptin-activated neurons in the rat brain. J Comp Neurol 423:261-281
37. Franklin K, Paxinos G 1997 The mouse brain in stereotaxic coordinates. San Diego: Academic Press
38. -/- mice. Endocrinology 139:3127-3132
39. Drucker DJ 2003 Glucagon-like peptides: regulators of cell proliferation, differentiation and apoptosis. Mol Endocrinol 17:161-171
40. Ling Z, Wu D, Zambre Y, Flamez D, Drucker DJ, Pipeleers DG, Schuit FC 2001 Glucagon-like peptide 1 receptor signaling influences topography of islet cells in mice. Virchows Arch 438:382-387
41. Inokuchi A, Oomura Y, Nishimura H 1984 Effect of intracerebroventricularly infused glucagon on feeding behavior. Physiol Behav 33:397-400
42. Turton MD, O'Shea D, Gunn I, Beak SA, Edwards CMB, Meeran K, Choi SJ, Taylor GM, Heath MM, Lambert PD, Wilding JPH, Smith DM, Ghatei MA, Herbert J, Bloom SR 1996 A role for glucagon-like peptide-1 in the central regulation of feeding. Nature 379:69-72
43. Verdich C, Flint A, Gutzwiller JP, Naslund E, Beglinger C, Hellstrom PM, Long SJ, Morgan LM, Holst JJ, Astrup A 2001 A meta-analysis of the effect of glucagon-like peptide-1 (7-36) amide on ad libitum energy intake in humans. J Clin Endocrinol Metab 86:4382-4389
44. Schwartz Sorensen S, Eiskjaer H, Orskov H, Bjerregaard Pedersen E 1993 Effect of intravenous glucagon infusion on renal haemodynamics and renal tubular handling of sodium in healthy humans. Scand J Clin Lab Invest 53:25-34
45. Ahloulay M, Bouby N, Machet F, Kubrusly M, Coutaud C, Bankir L 1992 Effects of glucagon on glomerular filtration rate and urea and water excretion. Am J Physiol 263:F24-F36
46. Necheles H, Sporn J, Walker L 1966 Effect of glucagon on gastrointestinal motility. Am J Gastroenterol 45:34-39
47. Patel GK, Whalen GE, Soergel KH, Wu WC, Meade RC 1979 Glucagon effects on the human small intestine. Dig Dis Sci 24:501-508
48. Schirra J, Kuwert P, Wank U, Leicht P, Arnold R, Goke B, Katschinski M 1997 Differential effects of subcutaneous GLP-1 on gastric emptying, antroduodenal motility, and pancreatic function in men. Proc Assoc Am Physicians 109:84-97
49. Tolessa T, Gutniak M, Hoist JJ, Efendic S, Hellstrom PM 1998 Inhibitory effect of glucagon-like peptide-1 on small bowel motility. J Clin Invest 102:764-774
50. Svoboda M, Tastenoy M, Vertongen P, Robberecht P 1994 Relative quantitative analysis of glucagon receptor mRNA in rat tissues. Mol Cell Endocrinol 105:131-137
51. Dunphy JL, Taylor RG, Fuller PJ 1998 Tissue distribution of rat glucagon receptor and GLP-1 receptor gene expression. Mol Cell Endocrinol 141:179-186
52. Parmley WW, Glick G, Sonnenblick EH 1968 Cardiovascular effects of glucagon in man. N Engl J Med 279:12-17
53. Farah AE 1983 Glucagon and the circulation. Pharmacol Rev 35:181-217
54. Love JN, Sachdeva DK, Bessman ES, Curtis LA, Howell JM 1998 A potential role for glucagon in the treatment of drug-induced symptomatic bradycardia. Chest 114:323-326
55. White CM 1999 A review of potential cardiovascular uses of intravenous glucagon administration. J Clin Pharmacol 39:442-447
56. Mery PF, Brechler V, Pavoine C, Pecker F, Fischmeister R 1990 Glucagon stimulates the cardiac Ca2+ current by activation of adenylyl cyclase and inhibition of phosphodiesterase. Nature 345:158-161
57. Sauvadet A, Rohn T, Pecker F, Pavoine C 1996 Synergistic actions of glucagon and mirdglucagon on Ca2+ mobilization in cardiac cells. Circ Res 78:102-109
58. Parker JC, Andrews KM, Allen MR, Stock JL, McNeish JD 2002 Glycemic control in mice with targeted disruption of the glucagon receptor gene. Biochem Biophys Res Commun 290:839-843
59. Rinaman L 1999 Interoceptive stress activates glucagon-like peptide-1 neurons that project to the hypothalamus. Am J Physiol 277:R582-R590
60. van Dijk G, Thiele TE 1999 Glucagon-like peptide-1 (7-36) amide: a central regulator of satiety and interoceptive stress. Neuropeptides 33:406-414
61. Toft-Nielsen MB, Madsbad S, Hoist JJ 1999 Continuous subcutaneous infusion of glucagon-like peptide 1 lowers plasma glucose and reduces appetite in type 2 diabetic patients. Diabetes Care 22:1137-1143
62. Zander M, Madsbad S, Madsen JL, Hoist JJ 2002 Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and β-cell function in type 2 diabetes: a parallel-group study. Lancet 359:824-830